• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN AND SHURTLEFF, INC DELTAPAQ - CERECYTE MICROCOIL; CNV DCS COILS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN AND SHURTLEFF, INC DELTAPAQ - CERECYTE MICROCOIL; CNV DCS COILS Back to Search Results
Catalog Number CDF10015430
Device Problems Difficult To Position (1467); Material Protrusion/Extrusion (2979)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/03/2015
Event Type  malfunction  
Manufacturer Narrative
It is unknown at this time if the device will be available for analysis.A review of the manufacturing documentation associated with this lot presented no issues during the manufacturing or inspection process that can be related to the reported complaint.Additional information will be submitted within 30 days of receipt.
 
Event Description
During the stent assisted coil embolization of an ophthalmic artery aneurysm, the deltapaq coil (b)(4) did not conform well to the aneurysm wall, and when repositioning, the surgeon noted the delivery wire herniated from the sheath and could not be resheathed.The device was then removed with the unspecified microcatheter.It was reported that the procedure was performed as per the instructions for use (ifu) and a continuous flush had been maintained through the microcatheter.There was no premature detachment or damage to the actual coil.The surgeon changed to a new coil and microcatheter to complete the surgery.There was no report of patient injury or clinically significant delay in the procedure.The aneurysm was 3.3 x 4.05mm with a neck width of 2.6 mm.The device was not available to be returned.
 
Manufacturer Narrative
Correction: it was initially reported that it was unknown if the device would be returned; however, the device was returned for analysis on 5/8/2015.Complaint conclusion: the device was returned for analysis.The coil was returned undamaged.The proximal pull tab section containing the locking mechanism has been severed and not returned.The resheathing tool has been separated off the sheath causing the core wires protrusion.The sheath has been severed and cut by an unidentified sharp straight edge tool of unknown origin.There is no mechanical sheath damage at the protrusion site.No manufacturing defects were found.Based on limited information and with the return of the undamaged coil, it cannot be determined why the coil did not conform to the aneurysm wall.Furthermore, it is important to note that it was unreported as to why the unidentified microcatheter was replaced after the complaint coil was removed from the patient.Concerning the resheathing difficulty, it was found that the severing of the sheaths pull tab containing the locking mechanism and ball tip allowed the resheathing tool to separate from the introducer sheath.This allowed the core wire to protrude outside the sheath.In this condition, resheathing the coil cannot be performed.The circumstances of how and when the sheath was severed and not returned cannot be determined.In addition, without the identification or the return of the unknown microcatheter and the severed proximal end of the sheath used in the procedure, it cannot be determined if these components had any contributions to the complaint event.A review of the manufacturing documentation associated with this lot presented no issues during the manufacturing or inspection process that can be related to the reported complaint.The coil poor conformity to the aneurysm wall could not be confirmed during product analysis since the coils was returned undamaged.The sheath herniation was confirmed; however, the damage found on the sheath was related to post-procedural damage since it was reported that the sheath was not damaged during use.The root cause of the coil not confirming to the aneurysm and the sheath herniation could not be determined; however, procedural/handling factors may have contributed.There was no evidence of a manufacturing issue related to the event; therefore, no corrective/preventive actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTAPAQ - CERECYTE MICROCOIL
Type of Device
CNV DCS COILS
Manufacturer (Section D)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA
Manufacturer Contact
duane durbin
821 fox lane
san jose, CA 95131
5088288310
MDR Report Key4742370
MDR Text Key16611588
Report Number2954740-2015-00105
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K080437
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 04/08/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/22/2018
Device Catalogue NumberCDF10015430
Device Lot NumberC17541
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/08/2015
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/08/2015
Initial Date FDA Received05/01/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/14/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/23/2013
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age58 YR
-
-